-+ 0.00%
-+ 0.00%
-+ 0.00%

Argus Research Maintains Buy on DexCom, Raises Price Target to $96

Benzinga·08/04/2026 14:17:29
Listen to the news
Argus Research analyst Steve Silver maintains DexCom (NASDAQ:DXCM) with a Buy and raises the price target from $86 to $96.